EuBiologics Co Ltd
206650
Company Profile
Business description
EuBiologics Co Ltd is a biopharmaceutical company, which develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine, Inaba Cairo, and among others.
Contact
6F Bomnal-A-Chim B/D Mabang-ro 8
Seocho-gu
Seoul06778
KORT: +82 25726675
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
353
Stocks News & Analysis
stocks
A collection of our best stock opportunities
Our latest articles about where we see opportunities in the market.
stocks
Morningstar analyst reacts to Macquarie Group’s earnings
Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks
Undervalued ASX share showing progress in global efforts
More clarity on the path forward in the UK.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,966.70 | 3.20 | 0.04% |
CAC 40 | 7,912.02 | 111.14 | 1.42% |
DAX 40 | 24,276.47 | 306.11 | 1.28% |
Dow JONES (US) | 44,837.56 | 64.36 | -0.14% |
FTSE 100 | 9,139.92 | 58.48 | 0.64% |
HKSE | 25,524.45 | 37.68 | -0.15% |
NASDAQ | 21,178.58 | 70.27 | 0.33% |
Nikkei 225 | 40,674.55 | 323.72 | -0.79% |
NZX 50 Index | 12,936.41 | 25.67 | 0.20% |
S&P 500 | 6,389.77 | 1.13 | 0.02% |
S&P/ASX 200 | 8,704.60 | 6.90 | 0.08% |
SSE Composite Index | 3,609.71 | 11.77 | 0.33% |